iTeos Therapeutics, Inc.
ITOSDelisted Aug 29, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001808865
iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.
Q2 2023 vs. Q1 2023
How the institutions holding iTeos Therapeutics, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 153 | 146 | −7 |
| Shares | 36.0M | 34.8M | −1.22M (−3.4%) |
| Value | $488.9M | $460.4M | −$28.4M (−5.8%) |
New holders (18)
Institutions that held iTeos Therapeutics, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank of Montreal | 171,389 | $3.10M | 0.00% |
| Verition Fund Management LLC | 116,283 | $1.54M | 0.02% |
| Empowered Funds, LLC | 101,304 | $1.34M | 0.05% |
| EA Series Trust | 101,304 | $1.34M | 0.05% |
| Readystate Asset Management LP | 88,391 | $1.17M | 0.12% |
| Jane Street Group, LLC | 61,135 | $809.4K | 0.00% |
| Algert Global LLC | 41,590 | $550.7K | 0.02% |
| Voya Investment Management LLC | 21,775 | $288.3K | 0.00% |
| Qube Research & Technologies Ltd | 16,413 | $217.3K | 0.00% |
| ExodusPoint Capital Management, LP | 15,418 | $204.0K | 0.00% |
| Franklin Resources Inc | 12,072 | $159.8K | 0.00% |
| Worth Venture Partners, LLC | 10,900 | $144.3K | 0.08% |
| Manufacturers Life Insurance Company, The | 10,296 | $136.3K | 0.00% |
| Exchange Traded Concepts, LLC | 9,624 | $127.4K | 0.00% |
| C M Bidwell & Associates Ltd | 3,929 | $52.0K | 0.04% |
| Aquatic Capital Management LLC | 1,400 | $19.0K | 0.00% |
| 25 LLC | 34 | $473 | 0.00% |
| Parkside Financial Bank & Trust | 8 | $106 | 0.00% |
Sold out (25)
Institutions that held iTeos Therapeutics, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.